ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,535 | -74.2% | 102,691 | +0.0% | 0.00% | – |
| Q2 2023 | $52,363 | -19.0% | 102,672 | 0.0% | 0.00% | – |
| Q1 2023 | $64,683 | -2.9% | 102,672 | 0.0% | 0.00% | – |
| Q4 2022 | $66,644 | -62.3% | 102,672 | 0.0% | 0.00% | – |
| Q3 2022 | $177,000 | +36.2% | 102,672 | -1.9% | 0.00% | – |
| Q2 2022 | $130,000 | -71.0% | 104,612 | -84.8% | 0.00% | – |
| Q1 2022 | $448,000 | -40.2% | 687,184 | 0.0% | 0.00% | – |
| Q4 2021 | $749,000 | -40.0% | 687,184 | +0.1% | 0.00% | – |
| Q3 2021 | $1,249,000 | -26.1% | 686,480 | +7.2% | 0.00% | – |
| Q2 2021 | $1,691,000 | -52.9% | 640,438 | -35.7% | 0.00% | -100.0% |
| Q1 2021 | $3,588,000 | +57.0% | 996,634 | +9.9% | 0.00% | – |
| Q4 2020 | $2,286,000 | -1.8% | 906,914 | -1.9% | 0.00% | -100.0% |
| Q3 2020 | $2,328,000 | -23.3% | 924,108 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $3,034,000 | +48.9% | 924,927 | +11.2% | 0.00% | 0.0% |
| Q1 2020 | $2,037,000 | -37.3% | 831,436 | +20.8% | 0.00% | 0.0% |
| Q4 2019 | $3,248,000 | +17.3% | 687,998 | +6.4% | 0.00% | 0.0% |
| Q3 2019 | $2,768,000 | -26.5% | 646,697 | +0.1% | 0.00% | 0.0% |
| Q2 2019 | $3,765,000 | +69.8% | 645,883 | +12.2% | 0.00% | 0.0% |
| Q1 2019 | $2,217,000 | +107.4% | 575,639 | +0.7% | 0.00% | – |
| Q4 2018 | $1,069,000 | -44.4% | 571,804 | -4.8% | 0.00% | – |
| Q3 2018 | $1,923,000 | +5.4% | 600,741 | -0.6% | 0.00% | – |
| Q2 2018 | $1,825,000 | -24.9% | 604,293 | -2.5% | 0.00% | -100.0% |
| Q1 2018 | $2,430,000 | -4.1% | 619,831 | +1.2% | 0.00% | 0.0% |
| Q4 2017 | $2,535,000 | -33.3% | 612,335 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $3,798,000 | -0.2% | 618,508 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $3,804,000 | +0.3% | 611,533 | +2.2% | 0.00% | 0.0% |
| Q1 2017 | $3,794,000 | +20.4% | 598,406 | +1.6% | 0.00% | 0.0% |
| Q4 2016 | $3,150,000 | -0.6% | 588,754 | +4.7% | 0.00% | 0.0% |
| Q3 2016 | $3,168,000 | -5.3% | 562,587 | -7.7% | 0.00% | 0.0% |
| Q2 2016 | $3,347,000 | -23.3% | 609,675 | +3.7% | 0.00% | 0.0% |
| Q1 2016 | $4,363,000 | -11.7% | 587,975 | -1.1% | 0.00% | 0.0% |
| Q4 2015 | $4,941,000 | -10.5% | 594,611 | -3.0% | 0.00% | -50.0% |
| Q3 2015 | $5,523,000 | -38.9% | 612,984 | -18.6% | 0.00% | 0.0% |
| Q2 2015 | $9,032,000 | +48.4% | 752,745 | +33.2% | 0.00% | 0.0% |
| Q1 2015 | $6,088,000 | +127.2% | 565,217 | +7.0% | 0.00% | +100.0% |
| Q4 2014 | $2,679,000 | +88.0% | 528,349 | -2.1% | 0.00% | – |
| Q3 2014 | $1,425,000 | -61.8% | 539,805 | -41.7% | 0.00% | -100.0% |
| Q2 2014 | $3,730,000 | +76.5% | 925,562 | +100.6% | 0.00% | 0.0% |
| Q1 2014 | $2,113,000 | +21.1% | 461,314 | +14.7% | 0.00% | – |
| Q4 2013 | $1,745,000 | -41.3% | 402,239 | -46.7% | 0.00% | – |
| Q3 2013 | $2,974,000 | +277.9% | 754,434 | +102.5% | 0.00% | – |
| Q2 2013 | $787,000 | – | 372,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |